{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:28:53Z","timestamp":1790234933068,"version":"4.1.0"},"reference-count":44,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pneumologie"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1055\/a-2497-5902","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T23:40:26Z","timestamp":1739403626000},"page":"170-183","source":"Crossref","is-referenced-by-count":2,"title":["Management des malignen Pleuraergusses"],"prefix":"10.1055","volume":"79","author":[{"given":"Christopher","family":"Larisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Stefan","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2365-4803","authenticated-orcid":false,"given":"Michael","family":"Ried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3238\/arztebl.2013.0313","article-title":"Behandlungskonzepte der Pleurakarzinose mit malignem Pleuraerguss","volume":"110","author":"M Ried","year":"2013","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1136\/thoraxjnl-2016-208989","article-title":"Cochrane corner: interventions for the management of malignant pleural effusions","volume":"71","author":"AO Clive","year":"2016","journal-title":"Thorax"},{"issue":"S 2","key":"ref3","doi-asserted-by":"publisher","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","article-title":"Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010","volume":"65","author":"ME Roberts","year":"2010","journal-title":"Thorax"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"CD010529","DOI":"10.1002\/14651858.CD010529.pub3","article-title":"Interventions for the management of malignant pleural effusions: a network meta-analysis","volume":"4","author":"A Dipper","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/jso.22100","article-title":"Multidisciplinary management of malignant pleural effusion","volume":"105","author":"JT Kaifi","year":"2012","journal-title":"J Surg Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/thorax-2023-220304","article-title":"British Thoracic Society Guideline for pleural disease","volume":"78","author":"ME Roberts","year":"2023","journal-title":"Thorax"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/ejcts\/ezy258","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"55","author":"AC Bibby","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/qjmed\/hct245","article-title":"Malignant pleural effusion","volume":"107","author":"AM Egan","year":"2014","journal-title":"QJM"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1053574","DOI":"10.3389\/fonc.2022.1053574","article-title":"Malignant pleural effusion: Updates in diagnosis, management and current challenges","volume":"12","author":"DN Addala","year":"2022","journal-title":"Front Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s00259-019-04287-7","article-title":"Development and validation of the PET-CT score for diagnosis of malignant pleural effusion","volume":"46","author":"MF Yang","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"S 2","key":"ref11","doi-asserted-by":"publisher","first-page":"ii4","DOI":"10.1136\/thx.2010.136978","article-title":"Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010","volume":"65","author":"C Hooper","year":"2010","journal-title":"Thorax"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1801254","DOI":"10.1183\/13993003.01254-2018","article-title":"Investigating unilateral pleural effusions: the role of cytology","volume":"52","author":"DT Arnold","year":"2018","journal-title":"Eur Respir J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.5114\/wiitm.2023.128070","article-title":"Current overview of awake, non-intubated, video-assisted thoracic surgery","volume":"18","author":"F Yanik","year":"2023","journal-title":"Wideochir Inne Tech Maloinwazyjne"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/17476348.2023.2266377","article-title":"Thoracic ultrasound-guided real-time pleural biopsy in the diagnosis of pleural diseases: a systematic review and meta-analysis","volume":"17","author":"Q Zhang","year":"2023","journal-title":"Expert Rev Respir Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/03936155231158661","article-title":"Pleural CEA, CA-15\u20133, CYFRA 21\u20131, CA-19\u20139, CA-125 discriminating malignant from benign pleural effusions: Diagnostic cancer biomarkers","volume":"38","author":"F Fazli Khalaf","year":"2023","journal-title":"Int J Biol Markers"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/03936155231158125","article-title":"Diagnosis of malignant pleural effusion with combinations of multiple tumor markers: A comparison study of five machine learning models","volume":"38","author":"Y Zhang","year":"2023","journal-title":"Int J Biol Markers"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"14022","DOI":"10.3390\/ijms241814022","article-title":"MicroRNAs Present in Malignant Pleural Fluid Increase the Migration of Normal Mesothelial Cells In Vitro and May Help Discriminate between Benign and Malignant Effusions","volume":"24","author":"M Marques","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3238\/arztebl.m2022.0229","article-title":"The treatment of malignant pleural effusion with permanent indwelling pleural catheters","volume":"119","author":"HS Hofmann","year":"2022","journal-title":"Dtsch Arztebl Int"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1001\/jama.2015.16840","article-title":"Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients with Malignant Pleural Effusion: The TIME1 Randomized Clinical Trial","volume":"314","author":"NM Rahman","year":"2015","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1510\/icvts.2010.254789","article-title":"What is the best treatment for malignant pleural effusions?","volume":"12","author":"I Zahid","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11606-010-1472-0","article-title":"Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review","volume":"26","author":"ME Van Meter","year":"2011","journal-title":"J Gen Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1513\/AnnalsATS.202007-886OC","article-title":"Association between Tunneled Pleural Catheter Use and Infection in Patients Immunosuppressed from Antineoplastic Therapy. A Multicenter Study","volume":"18","author":"CL Wilshire","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"110976","DOI":"10.1016\/j.ejrad.2023.110976","article-title":"Tract seeding in indwelling pleural catheter placement for the drainage of malignant pleural effusions: Incidence and related clinical and imaging factors","volume":"166","author":"YG Song","year":"2023","journal-title":"Eur J Radiol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12890-019-1002-8","article-title":"Indwelling pleural catheters for malignancy-associated pleural effusion: report on a single centre\u2019s ten years of experience","volume":"19","author":"N Frost","year":"2019","journal-title":"BMC Pulm Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"975","DOI":"10.6004\/jnccn.2012.0102","article-title":"Optimal management of malignant pleural effusions (results of CALGB 30102)","volume":"10","author":"TL Demmy","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial","volume":"307","author":"HE Davies","year":"2012","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/jama.2017.17426","article-title":"Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients with Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial","volume":"318","author":"R Thomas","year":"2017","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1513\/AnnalsATS.201807-495OC","article-title":"Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions. A Systematic Review and Meta-Analysis","volume":"16","author":"NP Iyer","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","article-title":"Randomized Trial of Pleural Fluid Drainage Frequency in Patients with Malignant Pleural Effusions. The ASAP Trial","volume":"195","author":"MM Wahidi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S2213-2600(18)30288-1","article-title":"Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial","volume":"6","author":"S Muruganandan","year":"2018","journal-title":"Lancet Respir Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1111\/1759-7714.14534","article-title":"Postoperative outcome after palliative treatment of malignant pleural effusion","volume":"13","author":"T Markowiak","year":"2022","journal-title":"Thorac Cancer"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1378\/chest.11-2657","article-title":"Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion","volume":"142","author":"ETH Fysh","year":"2012","journal-title":"Chest"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S2213-2600(21)00353-2","article-title":"Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial","volume":"10","author":"I Psallidas","year":"2022","journal-title":"Lancet Respir Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13063-015-0563-y","article-title":"The efficacy of indwelling pleural catheter placement versus placement plus talc sclerosant in patients with malignant pleural effusions managed exclusively as outpatients (IPC-PLUS): study protocol for a randomised controlled trial","volume":"16","author":"R Bhatnagar","year":"2015","journal-title":"Trials"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1056\/NEJMoa1716883","article-title":"Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion","volume":"378","author":"R Bhatnagar","year":"2018","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/LBR.0000000000000186","article-title":"Pleuroscopic Pleurodesis Combined With Tunneled Pleural Catheter for Management of Malignant Pleural Effusion: A Prospective Observational Study","volume":"22","author":"Z Boujaoude","year":"2015","journal-title":"J Bronchology Interv Pulmonol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1378\/chest.127.3.909","article-title":"Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion","volume":"127","author":"CM Dresler","year":"2005","journal-title":"Chest"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1001\/jama.2019.19997","article-title":"Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial","volume":"323","author":"R Bhatnagar","year":"2020","journal-title":"JAMA"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ejcts.2005.12.025","article-title":"The evidence on the effectiveness of management for malignant pleural effusion: a systematic review","volume":"29","author":"C Tan","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.12688\/f1000research.5538.2","article-title":"Malignant pleural effusions and the role of talc poudrage and talc slurry: a systematic review and meta-analysis","volume":"3","author":"S Mummadi","year":"2014","journal-title":"F1000Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1378\/chest.128.6.4041","article-title":"Influence of antiinflammatory drugs (methylprednisolone and diclofenac sodium) on experimental pleurodesis induced by silver nitrate or talc","volume":"128","author":"LR Teixeira","year":"2005","journal-title":"Chest"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1378\/chest.117.1.79","article-title":"Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions","volume":"117","author":"JE Heffner","year":"2000","journal-title":"Chest"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12890-015-0025-z","article-title":"Important prognostic factors for survival in patients with malignant pleural effusion","volume":"15","author":"MM Zamboni","year":"2015","journal-title":"BMC Pulm Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score","volume":"69","author":"AO Clive","year":"2014","journal-title":"Thorax"}],"container-title":["Pneumologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2497-5902.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T23:40:57Z","timestamp":1739403657000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2497-5902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":44,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2025,2,12]]},"published-print":{"date-parts":[[2025,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2497-5902","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0934-8387","1438-8790"],"issn-type":[{"value":"0934-8387","type":"print"},{"value":"1438-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}